Back to mobile site

Theravance Biopharma (TBPH) to Sell VIBATIV to Cumberland Pharmaceuticals (CPIX)

November 6, 2018 8:31 AM EST Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the sale of its proprietary antibiotic, VIBATIVĀ® (telavancin) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login